Checkpoint Therapeutics, Inc. Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Description of Securities of Checkpoint Therapeutics, Inc (Filed With SEC on March 22, 2024)
- Form of Inducement Letter Agreement, dated as of October 2, 2023, by and between Checkpoint Therapeutics, Inc. and the Holder (Filed With SEC on October 3, 2023)
- Description of Securities of Checkpoint Therapeutics, Inc (Filed With SEC on March 31, 2023)
- Description of Securities of Checkpoint Therapeutics, Inc (Filed With SEC on March 28, 2022)
- Description of Securities of Checkpoint Therapeutics, Inc (Filed With SEC on March 12, 2021)
- Description of Securities of Checkpoint Therapeutics, Inc (Filed With SEC on March 11, 2020)
- Certificate of Amendment of Amended and Restated Certificate of Incorporation of Checkpoint Therapeutics, Inc., dated June 14, 2018 (Filed With SEC on August 7, 2018)
- First Amendment to Amended and Restated Founders Agreement (Filed With SEC on November 3, 2017)
- CHECKPOINTTHERAPEUTICS, INC. AMENDEDAND RESTATED 2015 INCENTIVEPLAN ARTICLE1 PURPOSE (Filed With SEC on August 9, 2017)
- SECOND AMENDMENT TO SUBLICENSE AGREEMENT (Filed With SEC on May 10, 2017)
- FIRST AMENDMENT TO SUBLICENSE AGREEMENT (Filed With SEC on March 17, 2017)
- EXTENSION OF OPTION AGREEMENT (Filed With SEC on March 17, 2017)
- SECOND AMENDMENT TO EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on March 17, 2017)
